
The most widely used abortion medication in the United States has spent the better part of three years fighting for its survival in the courts, its future shaped as much by politics and ideology as by science.
Mifepristone, approved by the US Food and Drug Administration (FDA) in September 2000, now accounts for more than 60% of all abortions in the country, according to data compiled by KFF. Over 7.5 million people have used it since its original approval. Yet despite its established safety record, a years-long legal assault has placed it at the centre of America's most charged and consequential reproductive rights battle.